Jefferies Financial Group Inc. Adma Biologics, Inc. Transaction History

Jefferies Financial Group Inc.

  • $15.9 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$5.98 - $11.18 $1.48 Million - $2.77 Million
-248,000 Reduced 73.81%
88,000 $983,000
Q1 2024

May 13, 2024
SELL
$4.4 - $6.74 $8.47 Million - $13 Million
-1,924,000 Reduced 85.13%
336,000 $2.22 Million
Q4 2023

Feb 13, 2024
BUY
$3.08 - $4.52 $6.96 Million - $10.2 Million
2,260,000 New
2,260,000 $10.2 Million

Others Institutions Holding ADMA

# of Institutions
339
Shares Held
182M
Call Options Held
1.72M
Put Options Held
846K
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.22B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email